Evidence map›Paper›PMID 21234651›Full record

ArticleMolecular and cellular biochemistry2011

Lipocalin 2 deficiency inhibits cell proliferation, autophagy, and mitochondrial biogenesis in mouse embryonic cells.

Daozhong Jin, Yuanyuan Zhang, Xiaoli Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Knocking out Fkbp51 decreases CClCell & bioscience · 2024
    Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Daozhong JinDepartment of Food Science and Nutrition, University of Minnesota-Twin Cities, St Paul, MN 55108-1038, USA.
Yuanyuan Zhang
Xiaoli Chen
University of Minnesota · US

Funding

Lipocalin 2 in Inflammation and Metabolic ControlR01DK080743 · NIDDK · UNIVERSITY OF MINNESOTA · PI CHEN, XIAOLI · 2008 to 2012
$1.5M
NIDDK NIH HHS R01 DK080743NIDDK NIH HHS R01DK080743
6 · The paper itself

Abstract

Lipocalin 2 (LCN2) has been recently implicated as a critical player in multiple cancer tumorigeneses. However, the molecular mechanisms for its tumorigenic role are poorly understood. Herein, we investigated the effects of LCN2 on cell proliferation, autophagy, and mitochondrial biogenesis in MEF cells. We observed that LCN2 deficiency significantly inhibited cell proliferation and autophagy in MEF cells. Furthermore, mitochondrial DNA content, mRNA expression levels of mitochondrial-encoded gene cytochrome oxidase 2 and PGC-1α were all markedly reduced in LCN2⁻/⁻ MEF cells. Additionally, when compared with wild-type MEF cells, LCN2⁻/⁻ MEF cells expressed significantly higher levels of IRS-1, and displayed more potent TNFα-stimulated NF-κB activation. These findings demonstrate that LCN2 is a critical regulator of cell proliferation, autophagy, and mitochondrial biogenesis.

Indexed as

Cell ProliferationAcute-Phase ProteinsAnimalsAutophagyBlotting, WesternCells, CulturedLipocalin-2LipocalinsMiceMice, KnockoutMitochondriaOncogene ProteinsPolymerase Chain ReactionAcute-Phase ProteinsLcn2 protein, mouseLipocalin-2LipocalinsOncogene Proteins

Identifiers

PMID21234651
OpenAlexW2144542019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.